Noraxon Presents New Product at the American Physical Therapy Association Combined Sections Meeting 2004

SCOTTSDALE, Ariz. (Feb. 3, 2004) – Noraxon U.S.A. Inc announced that it will introduce its latest surface EMG (SEMG) instrument, the MyoSystem 1400A, at the American Physical Therapy Association (APTA) Combined Sections Meeting in Nashville, Tenn., Feb. 4 to 8, 2004. MyoSystem 1400A is a fully functional fixed-cable instrument that performs comprehensive muscle performance evaluations for clinicians, biomechanical researchers and sports medicine professionals.

“We have created a powerful measurement tool into one reliable package that monitors up to 16 channels of surface EMG and/or other analog signals,” said Randy Raisanen, president of Noraxon. “The MyoSystem 1400A now has a built in USB port that handles all data acquisition and greatly simplifies interfacing to a PC, making it more convenient for the user to concentrate on their analysis.”

The MyoSystem 1400A is available as a 4, 8, 12 or 16 channel unit. The instrument offers Noraxon’s internationally patent-protected amplifier technology to provide clean, consistent and reliable SEMG signals during any type of isometric or dynamic exercise. Additionally, the instrument is fully compatible with an extensive line of direct plug-in sensors and pre-amplifiers. This enables the MyoSystem 1400A to measure a variety of other analog signals, such as kinetic or kinematics variables in synchrony with EMG. MyoSystem 1400A is compliant with IEC60601-1 and IEC60601-2-40 electromyography standards and CE approved.

Representatives from Noraxon U.S.A. Inc. will be available to give demonstrations and discuss the company’s full line of products at the Gaylord Opryland Hotel, booth #823. To schedule a time for a product demonstration, please contact Noraxon’s marketing/sales department at (480) 443-3413 or info@noraxon.com.